Deltex Medical logo

DEMG - Deltex Medical Share Price

1.28p 0.0  0.0%

Last Trade - 13/09/19

Sector
Healthcare
Size
Micro Cap
Market Cap £6.58m
Enterprise Value £7.59m
Revenue £4.96m
Position in Universe 1626th / 1830
Bullish
Bearish
Unlock DEMG Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DEMG Revenue Unlock DEMG Revenue

Net Income

DEMG Net Income Unlock DEMG Revenue

Normalised EPS

DEMG Normalised EPS Unlock DEMG Revenue

PE Ratio Range

DEMG PE Ratio Range Unlock DEMG Revenue

Dividend Yield Range

DEMG Dividend Yield Range Unlock DEMG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DEMG EPS Forecasts Unlock DEMG Revenue
Profile Summary

Deltex Medical Group plc is a United Kingdom-based haemodynamic management company, which manufactures fluid management devices. The Company's segments are Probes and Other. The Company's Esophageal Doppler Simulator (EDS) enables clinicians to practice probe insertion, focussing and waveform interpretation outside of a patient setting. The Company's CardioQ-EDM and CardioQ-EDM+ esophageal Doppler monitors (EDM) are designed to allow clinicians to guide fluid and drug administration during surgery. The Company's oesophageal Doppler haemodynamic monitoring (ODM) uses ultrasound to measure blood flows in the central circulation of patients, and allows doctors to fine tune the circulation. Its probes include surgical probes, such as I2S and I2P, and critical care probes, such as I2C and EDP240. Its I2S and I2P are used in patients who are anesthetized, sedated or awake. Its EDP240 is used in patients under anesthesia or full sedation. It has operations in Spain and Canada, among others.

Directors
Last Annual December 31st, 2018
Last Interim December 31st, 2018
Incorporated January 6, 2000
Public Since August 20, 2001
No. of Shareholders: n/a
No. of Employees: 71
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 516,118,109
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DEMG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DEMG
Upcoming Events for DEMG
Monday 23rd September, 2019 Estimate
Half Year 2019 Deltex Medical Group PLC Earnings Release
Similar to DEMG
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.